What Fueled The Previous Growth In The Lyophilization Services For Biopharmaceuticals Market?
The lyophilization services for biopharmaceuticals market has seen considerable growth due to a variety of factors.
•In recent times, the market size for lyophilization services for biopharmaceuticals has experienced a swift expansion. The market, expected to increase from $1.82 billion in 2024 to $2.01 billion in 2025, is predicted to have a compound annual growth rate (CAGR) of 10.4%.
Factors that contributed to the growth during the historic period include the expansion of biopharmaceuticals, expiration of drug patents, a rise in personalized medicine, an increase in clinical trials, and the globalization of the biopharmaceuticals market.
What Is The Expected Growth In The Lyophilization Services For Biopharmaceuticals Market Size?
The lyophilization services for biopharmaceuticals market is expected to maintain its strong growth trajectory in upcoming years.
• The market for lyophilization services for biopharmaceuticals is projected to experience exponential growth in the coming years. The market is expected to expand to $3.01 billion in 2029, growing at a compound annual growth rate (CAGR) of 10.7%.
The expansion during this forecast period will be driven by the advent of MRNA and nucleic acid therapeutics, the outsourcing tendencies in the pharmaceutical industry, emphasis on continuous production, advancements in combination therapies, and growth of biosimilars production. Key trends for the forecast period encompass the adoption of quality-by-design (QBD), the integration of automation and robotics, sustainability considerations, customization for intricate molecules, and a shift towards uninterrupted lyophilization.
What Are the Critical Driver Fuelling the Lyophilization Services For Biopharmaceuticals Market's Growth?
The spike in need for biologics is set to stimulate the expansion of the lyophilization services industry for biopharmaceuticals. Biologics are therapeutic goods made from or containing aspects of living organisms. In the pharmaceutical and biopharmaceutical sectors, lyophilization services are extensively employed for biologics. This method aids in the preservation of biologic's stability, preventing them from denaturing or degrading. Additionally, it's advantageous for enhancing stability and bolstering product integrity. As an example, in November 2022, the Canadian Institute for Health Information, a Canada-based governmental health firm, reported that biologics made up 2.3% of claims and $4.4 billion (29.4%) of total public medication program expenditure in 2021. Moreover, the US Food and Drug Administration, a US federal agency within the Department of Health and Human Services, mentioned that by 2022's end, 40 biosimilars had been approved, with 27 being marketed in the US, where they were competing with 10 brand-name biologics. Consequently, the escalating demand for biologics propels the growth of the lyophilization services for the biopharmaceuticals market.
How Is the Lyophilization Services For Biopharmaceuticals Market segmented?
The lyophilization services for biopharmaceuticals market covered in this report is segmented –
1) By Type: Product And Cycle Development, Clinical Manufacturing, Commercial Manufacturing, Freeze Drying Analytical Services
2) By Type Of Primary Packaging System: Vials, Syringes, Cartridges, Ampoules, Other Primary Packaging Systems
3) By Application: Pharmaceutical And Biotechnology Companies, Research Institutes, Other Applications
Subsegments:
1) By Product And Cycle Development: Formulation Development, Cycle Optimization, Stability Studies
2) By Clinical Manufacturing: Small-Scale Production, Clinical Trial Material Production
3) By Commercial Manufacturing: Large-Scale Production, Bulk Product Manufacturing
4) By Freeze Drying Analytical Services: Product Characterization, Stability Testing, Process Validation
Pre-Book The Lyophilization Services For Biopharmaceuticals Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing the Lyophilization Services For Biopharmaceuticals Market?
Leading businesses that serve the biopharmaceutical lyophilization services sector are exploring modular design technologies to elevate their production processes' adaptability and scalability, make better use of their equipment, and swiftly adjust to shifting manufacturing demands. The modular design concept dissects a system into smaller, independent units or modules, providing easy customization, smooth reconfiguration, and efficient component replacement without impacting the entire system. For example, in June 2024, the German machinery industry enterprise, Syntegon Technology, introduced the Modular Bioprocessing Platform (MBP). This platform is modular, facilitating customization for an array of applications like microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. As a result, this design permits biopharmaceutical producers to promptly adapt to fluctuating production requirements without compromising quality.
Who Are the Key Players in the Lyophilization Services For Biopharmaceuticals Market?
Major companies operating in the lyophilization services for biopharmaceuticals market include:
• Strides Pharma Science Limited
• Baxter International Inc.
• Catalent Pharma Solutions Inc
• Emergent BioSolutions Inc.
• Vetter Pharma International GmbH
• Curia Global Inc.
• Corden Pharma GmbH
• Lyophilization Services of New England Inc.
• Jubilant HollisterStier LLC
• Dalton Pharma Services
• IDT Biologika GmbH
• Ardena Group
• Axcellerate Pharma LLC
• Symbiosis Pharmaceutical Services
• Biofortuna Limited
• Rentschler Fill Solutions GmbH
• Lyophilization Technology Inc.
• Pyramid Laboratories Inc
• AB BioTechnologies Inc.
• Biopharma Process Systems
• Labyrinth Biopharma LLC
• Gilyos GmbH
• ProJect Pharmaceutics GmbH
• BioZed Engineering Pvt. Ltd.
• Berkshire Sterile Manufacturing
• Millrock Technology Inc.
What Is The Most Dominant Region In The Lyophilization Services For Biopharmaceuticals Market?
North America was the largest region in the lyophilization services for biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyophilization services for biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
